Me. Stat. tit. 32 § 13841

Current through 131st (2023-2024) Legislature Chapter 684
Section 13841 - Authority
1.Engage in collaborative drug therapy management. A pharmacist licensed in this State who meets the qualifications and requirements of section 13842 and rules adopted by the board may engage in collaborative drug therapy management pursuant to a collaborative practice agreement with a practitioner.

[2013, c. 308, §4(NEW).]

2.Scope of authority. A pharmacist engaging in collaborative drug therapy management pursuant to subsection 1 is entitled to adequate access to a patient's history, disease status, drug therapy and laboratory and procedure results and may:
A. Collect and review a patient's history; [2013, c. 308, §4(NEW).]
B. Obtain and check vital signs; [2013, c. 308, §4(NEW).]
C. Order and evaluate the results of laboratory tests directly related to drug therapy under the supervision of, or in direct consultation with, a practitioner and in accordance with approved protocols applicable to the practice setting and when the evaluation does not include a diagnostic component; and [2013, c. 308, §4(NEW).]
D. Initiate, administer, monitor, modify and discontinue drug therapy for a particular patient pursuant to the collaborative practice agreement with a practitioner who is treating the patient, as long as the action is reported to the practitioner in a timely manner as determined by rules adopted pursuant to section 13846. [2021, c. 271, §5(AMD).]

[2021, c. 271, §5(AMD).]

32 M.R.S. § 13841

Amended by 2021SP1, c. 271,§ 5, eff. 10/18/2021.
Added by 2013, c. 308,§ 4, eff. 10/9/2013.